Home / United States / Xvivo Perfusion AB Ordinary Sh (XVIPF)
Xvivo Perfusion AB Ordinary Sh (XVIPF)
Short position disclosed on October 15, 2026. FINRA register read on November 4, 2026.
FINRA publishes, twice a month, the number of shares sold short in each company. Their share of the stock is computed here on the count the company reports to the SEC, and this market appears in no ranking shared with the others.
Evolution of the disclosed total
Open positions
| Fund | Twelve months | Shares sold short | Over the year | Since |
|---|---|---|---|---|
| Aggregated total | 424,596 shares | -47,598 shares | October 15, 2026 |
The funds named in Sweden
FINRA publishes a total and names nobody. This register names each fund short of the same company, as a share of its capital.
| Fund | % of capital | Since |
|---|---|---|
| JPMorgan Asset Management (UK) Ltd | 1.80% | November 3, 2026 |
| Marchant MC Ltd | 1.57% | May 8, 2026 |
| ActusRayPartners Limited | 0.69% | October 26, 2026 |
| D E Shaw Co LP | 0.59% | October 9, 2026 |
| AQR Capital Management LLC | 0.50% | September 24, 2026 |
Every disclosure: Xvivo Perfusion Aktiebolag
Get the moves on Xvivo Perfusion AB Ordinary Sh (XVIPF) by mail, at most once a day.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
| Date | Fund | Shares sold short | End of publication |
|---|---|---|---|
| October 15, 2026 | Aggregated total | 424,596 shares | still open |
| September 30, 2026 | Aggregated total | 430,289 shares | |
| September 15, 2026 | Aggregated total | 430,653 shares | |
| August 31, 2026 | Aggregated total | 426,411 shares | |
| August 14, 2026 | Aggregated total | 457,296 shares | |
| July 31, 2026 | Aggregated total | 455,955 shares | |
| July 15, 2026 | Aggregated total | 472,194 shares |
Download 7 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in the United States
- Wolfspeed, Inc. (WOLF) 51.66%
- Ondas Inc. Common Stock (ONDS) 44.50%
- Hertz Global Holdings, Inc Com (HTZ) 40.11%
- Eos Energy Enterprises, Inc. C (EOSE) 38.24%
- Shoe Station Group, Inc. Commo (SHOE) 36.36%
- Serve Robotics Inc. Common Sto (SERV) 36.00%
- BIO-key International, Inc. Co (BKYI) 35.61%
- C4 Therapeutics, Inc. Common S (CCCC) 34.73%
- Capricor Therapeutics, Inc. Co (CAPR) 34.16%
- TripAdvisor, Inc. Common Stock (TRIP) 32.76%
- PureCycle Technologies, Inc. C (PCT) 32.47%
- FuelCell Energy, Inc. Common S (FCEL) 32.28%
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Xvivo Perfusion AB Ordinary Sh (XVIPF), source FINRA, data as at October 15, 2026, https://www.quivad.com/action/xvivo-perfusion-ab-ordinary-sh-xvipf
Embed the chart
<iframe src="https://www.quivad.com/embed/action/xvivo-perfusion-ab-ordinary-sh-xvipf" width="600" height="280" title="Xvivo Perfusion AB Ordinary Sh (XVIPF)" loading="lazy" style="border:0"></iframe>
Badge
<a href="https://www.quivad.com/action/xvivo-perfusion-ab-ordinary-sh-xvipf"><img src="https://www.quivad.com/action/xvivo-perfusion-ab-ordinary-sh-xvipf/badge.svg" alt="QuiVad, Xvivo Perfusion AB Ordinary Sh (XVIPF)"></a>